Publications by Julie Errington - ePrints

Browsing publications by Julie Errington.

Newcastle Authors	Title	Year
Julie Errington Dr Shelby Barnett Professor Gareth Veal	Spontaneous fractures during 13-cis retinoic acid therapy for neuroblastoma	2023
Dr Catherine Gowland Philip Berry Julie Errington Professor Gareth Veal	Development of a LC-MS/MS method for the quantification of toxic payload DM1 cleaved from BT1718 in a Phase I study	2021
Dr Shelby Barnett Julie Errington Julieann Sludden Dr David Jamieson Professor Gareth Veal et al.	Pharmacokinetics and pharmacogenetics of cyclophosphamide in a neonate and infant childhood cancer patient population	2021
Professor Gareth Veal Professor Deborah Tweddle Julie Errington	Pharmacokinetics and safety of a novel oral liquid formulation of 13-cis retinoic acid in children with neuroblastoma: A randomized crossover clinical trial	2021
Dr Rosanna Jackson Philip Berry Julie Errington Professor Julie Irving Professor Gareth Veal et al.	Impact of dose and duration of therapy on dexamethasone pharmacokinetics in childhood acute lymphoblastic leukaemia - a report from the UKALL 2011 trial	2019
Professor Gareth Veal Julie Errington	Population pharmacokinetics of carboplatin, etoposide and melphalan in children: A re-evaluation of paediatric dosing formulas for carboplatin in patients with normal or mild impairment of renal function	2019
Professor Gareth Veal Julie Errington Dr Leigh McDonald Professor Deborah Tweddle	The use of pharmacokinetically guided carboplatin chemotherapy in a pre-term infant with neuroblastoma-associated spinal cord compression	2019
Professor Gareth Veal Julie Errington	Adaptive dosing of anticancer drugs in neonates – facilitating evidence-based dosing regimens	2016
Professor Gareth Veal Julieann Sludden Dr David Jamieson Julie Errington Dr Ghada Malik et al.	Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin’s lymphoma	2016
Julie Errington Dr Ghada Malik Lisa Price Professor Gareth Veal	Investigating the Experiences of Childhood Cancer Patients and Parents Participating in Optional Nontherapeutic Clinical Research Studies in the UK	2016
Professor Gareth Veal Julie Errington Dr James Hayden Professor Deborah Tweddle	Carboplatin therapeutic monitoring in preterm and full-term neonates	2015
Professor Gareth Veal Julie Errington Dr James Hayden Professor Deborah Tweddle	Carboplatin therapeutic monitoring in preterm and full-term neonates	2015
Professor Gareth Veal Julie Errington Professor Deborah Tweddle	Therapeutic drug monitoring approaches to the treatment of preterm and full-term neonates with cancer - A UK experience	2015
Dr Chris Hill Julie Errington Dr Ghada Malik Professor Alan Boddy Professor Gareth Veal et al.	Characterisation of the clinical pharmacokinetics of actinomycin D and the influence of ABCB1 pharmacogenetic variation on actinomycin D disposition in children with cancer	2014
Professor Gareth Veal Julie Errington Sophie Rowbotham Nicola Illingworth Dr Ghada Malik et al.	Adaptive dosing approaches to the individualization of 13-cis-retinoic acid (isotretinoin) treatment for children with high-risk neuroblastoma	2013
Professor Gareth Veal Julie Errington Dr Ghada Malik Dr Chris Hill Professor Alan Boddy et al.	Investigating the pharmacokinetics and dosing of anticancer drugs in infants and young children	2013
Julie Errington Professor Alan Boddy Professor Gareth Veal Mike Cole	Pharmacokinetics of cyclophosphamide and its metabolites in pediatric patients receiving high-dose myeloablative therapy	2011
Julie Errington Professor Alan Boddy Professor Gareth Veal Mike Cole	Pharmacokinetics of high-dose cyclophosphamide and its metabolites in paediatric patients	2011
Professor Gareth Veal Julie Errington Professor Andrew Pearson Professor Alan Boddy	Pharmacokinetics of carboplatin and etoposide in infant neuroblastoma patients	2010
Julie Errington Professor Alan Boddy Professor Gareth Veal	Therapeutic monitoring of carboplatin dosing in a premature infant with retinoblastoma	2009
Professor Gareth Veal Julie Errington Dr Michael Tilby Professor Alan Boddy	Adaptive dosing and platinum-DNA adduct formation in children receiving high-dose carboplatin for the treatment of solid tumours	2007
Professor Alan Boddy Melanie Griffin Julie Errington Professor Gareth Veal	Dosing of cancer patients with low or absent renal function	2007
Professor Gareth Veal Mike Cole Geoffrey Taylor Julie Errington Professor Alan Boddy et al.	Pharmacogenetics and metabolism of cyclophosphamide in paediatric cancer patients	2007
Professor Gareth Veal Mike Cole Julie Errington Professor Alan Boddy	Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma - A study of the United Kingdom Children's Cancer Study Group	2007
Professor Gareth Veal Julie Errington Huw Thomas Professor Alan Boddy	Biliary excretion of etoposide in children with cancer	2006
Professor Gareth Veal Mike Cole Julie Errington Annie Parry Dr Juliet Hale et al.	Pharmacokinetics of dactinomycin in a pediatric patient population: A United Kingdom Children's Cancer Study Group study	2005
Professor Gareth Veal Julie Errington Julieann Sludden Melanie Griffin Annie Parry et al.	Determination of anti-cancer drug actinomycin D in human plasma by liquid chromatography-mass spectrometry	2003
Julie Errington Professor Gareth Veal Julieann Sludden Melanie Griffin Professor Andrew Pearson et al.	Determination of the anti-cancer drug actinomycin D in human plasma by liquid chromatography-mass spectrometry	2003
Professor Gareth Veal Julie Errington Professor Andrew Pearson Professor Alan Boddy	Poster Presentation: Oxidative metabolism of 13-cis-retinoic acid in children with neuroblastoma	2003
Professor Gareth Veal Julie Errington Dr Chris Redfern Professor Andrew Pearson Professor Alan Boddy et al.	Influence of isomerisation on the growth inhibitory effects and cellular activity of 13-cis and all-trans retinoic acid in neuroblastoma cells	2002
Dr Xiaomei Lu Julie Errington Professor Nicola Curtin Professor John Lunec Professor Herbie Newell et al.	The impact of p53 status on cellular sensitivity to antifolate drugs	2001
Professor Gareth Veal Dr Cinera Dias Annie Parry Julie Errington Dr Juliet Hale et al.	Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy	2001
Professor Gareth Veal Julie Errington Dr Chris Redfern Professor Andrew Pearson Professor Alan Boddy et al.	Influence of retinoid isomerisation on the cellular activity of 13-cis retinoic acid in neuroblastoma	2001
Dr Xiaohong Lu Julie Errington Professor Nicola Curtin Professor Alan Boddy Professor Herbie Newell et al.	Cellular ATP depletion by LY309887 as a predictor of growth inhibition in human tumor cell lines	2000